Answers are grounded in this paper and cite their sources.
Links gene activation in type 3 innate lymphoid cells to autoimmune disease risk, suggesting new intervention targets.
Innate lymphoid cells (ILCs) are rare, tissue-resident lymphocytes that functionally mirror CD4+ T helper lineages but lack antigen receptors. Type 3 ILCs (ILC3s) are enriched at barrier sites, regulating inflammation and promoting tissue integrity. Here, we profile the promoter- anchored chromosomal contacts of primary human ILC3s using low-input Promoter Capture Hi-C (PCHi-C) and compare them with those in CD4+ T cells. We use these data to link Crohn’s disease genome-wide association study (GWAS) variants with target genes, detecting both known and unanticipated candidates, including CLN3, a causal gene for Batten disease. We show that Cln3 overexpression in a mouse ILC3-like cell line alters stimulation- induced transcriptional programmes and cytokine secretion. Extending our approach to five additional autoimmune GWAS traits reveals enrichment for regulators of ILC3 activation. Our work develops new methods, maps long-range gene control in ILC3s and prioritises autoimmune disease risk genes with roles in this clinically relevant immune cell type.
No takes yet. Share an insight, caveat, or question.
Chris Wallace (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: